Logo image
Sign in
Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy
Journal article   Peer reviewed

Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy

Bradley J. Monk, A. Facciabene, W. E. Brady, C. A. Aghajanian, P. M. Fracasso, J. L. Walker, H. A. Lankes, K. L. Manjarrez, G. H. Danet-Desnoyers, K. M. Bell-McGuinn, …
Clinical Cancer Research, Vol.23(8), pp.1955-1966
04/15/2017
PMID: 27702821

Metrics

4 Record Views

Details